Valeria Serban, MD
Psychiatry · Ridgewood, NYNPI 1306942933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 29.3% of the total.
Across 24 payments — averaging $24.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$170
- Amgen$105
- Novartis$64
- Teva Pharmaceuticals USA, Inc.$45
- Avanir Pharmaceuticals, Inc.$26
- Lundbeck LLC$25
- plus $146 from 8 others
What the payments were for
- Speaking & faculty fees$193%
- Food & beverage$56297%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 4 | $170 |
| Amgen | 3 | $105 |
| Novartis | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Lundbeck LLC | 1 | $25 |
| Sanofi | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Acorda Therapeutics, Inc | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$107
How this compares
$581 in reported general payments places this provider in the 70th percentile of 3,713 psychiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 11 | $15,436 |
| Lurasidone Hcl | 47 | $5,383 |
| Bupropion XlBupropion Hcl | 342 | $3,863 |
| Clozapine | 41 | $3,293 |
| Olanzapine | 123 | $3,055 |
| VascepaIcosapent Ethyl | 19 | $2,777 |
| Trazodone Hcl | 365 | $2,766 |
| Aripiprazole | 126 | $2,766 |
| Duloxetine Hcl | 122 | $2,725 |
| Ziprasidone Hcl | 39 | $2,622 |
| Hydroxyzine Hcl | 195 | $2,480 |
| Quetiapine Fumarate | 205 | $2,318 |
| Divalproex Sodium | 114 | $1,909 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 24 | $1,569 |
| Benztropine Mesylate | 188 | $1,541 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Ridgewood
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.